mci 176 has been researched along with Muscle Contraction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosono, M; Taira, N | 1 |
| Horii, D; Ishibashi, A | 1 |
2 other study(ies) available for mci 176 and Muscle Contraction
| Article | Year |
|---|---|
Coronary vasodilator versus cardiac effects of MCI-176, a novel quinazolinone calcium antagonist, in the dog heart.
Topics: Animals; Blood Flow Velocity; Calcium; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Female; Heart Conduction System; In Vitro Techniques; Male; Muscle Contraction; Papillary Muscles; Quinazolines; Quinazolinones; Sinoatrial Node; Vasodilation | 1987 |
Effect of MCI-176, a new calcium antagonist, on the calcium induced contraction of isolated porcine coronary arteries.
Topics: Animals; Calcium Channel Blockers; Calcium Chloride; Coronary Vessels; Diltiazem; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Quinazolines; Quinazolinones; Swine | 1987 |